Routine re-screening for latent tuberculosis has low utility in patients with chronic immune-mediated inflammatory diseases treated with biologics

Published: 13 May 2022| Version 1 | DOI: 10.17632/bg3rwjv6y8.1
Contributor:
Anthony Fernandez

Description

Routine re-screening for latent tuberculosis has low utility in patients with chronic immune-mediated inflammatory diseases treated with biologics J Am Acad Dermatol 2022 Supplemental Material

Files

Institutions

Cleveland Clinic

Categories

Dermatology, Gastroenterology, Rheumatology, Biologic Therapy, Health Screening, Tuberculosis Diagnosis

Licence